Aeterna Zentaris DPO Ratio 2011-2026 | AEZS

Annual DPO Ratio Aeterna Zentaris

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	34.4 K	90.8	107

All numbers in USD currency

Maximum	Minimum	Average
34.4 K	90.8	11.5 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Axsome Therapeutics AXSM	529	$ 156.92	-1.23 %	$ 7.81 B	USA
Kamada Ltd. KMDA	106	$ 8.5	-1.39 %	$ 260 M	Israel
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Benitec Biopharma BNTC	-556	$ 10.98	-4.52 %	$ 452 M	USA
Compugen Ltd. CGEN	82.7	$ 2.09	-0.95 %	$ 195 M	Israel
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
BioMarin Pharmaceutical BMRN	245	$ 54.13	-1.64 %	$ 10.4 B	USA
Curis CRIS	3.24 K	$ 0.77	1.89 %	$ 4.86 M	USA
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	507	$ 1.52	-5.59 %	$ 178 M	USA
Cellectis S.A. CLLS	975	$ 3.34	-4.02 %	$ 116 M	France
Arbutus Biopharma Corporation ABUS	23	$ 4.24	-2.97 %	$ 704 M	Canada
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
Cardiff Oncology CRDF	406	$ 1.8	-1.1 %	$ 120 M	USA
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA